Author
Listed:
- Rimjhim Agarwal
(La Jolla Institute for Immunology (LJI)
University of California San Diego (UCSD))
- Calvin Ha
(La Jolla Institute for Immunology (LJI))
- Fernanda H. Côrtes
(La Jolla Institute for Immunology (LJI)
Fiocruz)
- Yeji Lee
(La Jolla Institute for Immunology (LJI))
- Amparo Martínez-Pérez
(La Jolla Institute for Immunology (LJI))
- Rosa Isela Gálvez
(La Jolla Institute for Immunology (LJI))
- Izabella N. Castillo
(University of North Carolina School of Medicine)
- Elizabeth J. Phillips
(Murdoch University
Vanderbilt University School of Medicine)
- Simon A. Mallal
(Murdoch University
Vanderbilt University School of Medicine)
- Angel Balmaseda
(Sustainable Sciences Institute)
- Eva Harris
(Berkeley)
- Claudia M. Romero-Vivas
(Fundación Universidad del Norte)
- Lakshmanane Premkumar
(University of North Carolina School of Medicine)
- Andrew K. Falconar
(Fundación Universidad del Norte)
- Alba Grifoni
(La Jolla Institute for Immunology (LJI))
- Alessandro Sette
(La Jolla Institute for Immunology (LJI)
University of California San Diego (UCSD))
- Daniela Weiskopf
(La Jolla Institute for Immunology (LJI)
University of California San Diego (UCSD))
Abstract
Chikungunya virus (CHIKV), a mosquito-borne alphavirus, causes acute febrile illness that can progress into chronic arthritis-like disease (CHIKVD) in humans. CD4+ T cells have important functions in CHIKV infection, yet the CHIKV target proteins for these CD4 + T cells are poorly characterized. Here, by stimulating PBMCs collected from individuals with chronic CHIKVD with peptides spanning the entire CHIKV proteome, we provide a comprehensive landscape of CHIKV CD4+ T cell epitopes. We identify three immunodominant regions and associated core motifs in CHIKV E1, nsP1 and CP proteins. In addition, by in silico assessment of the sequence conservation of CHIKV proteome with closely related alphaviruses, we define CHIKV epitopes conserved across arthritogenic and encephalitic viruses. Overall, our work describes CD4+ T cell targets of CHIKV in humans, thereby assisting in studying the functions of CD4+ T cells in CHIKV pathogenesis and vaccine design.
Suggested Citation
Rimjhim Agarwal & Calvin Ha & Fernanda H. Côrtes & Yeji Lee & Amparo Martínez-Pérez & Rosa Isela Gálvez & Izabella N. Castillo & Elizabeth J. Phillips & Simon A. Mallal & Angel Balmaseda & Eva Harris , 2025.
"Identification of immunogenic and cross-reactive chikungunya virus epitopes for CD4+ T cells in chronic chikungunya disease,"
Nature Communications, Nature, vol. 16(1), pages 1-14, December.
Handle:
RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-60862-7
DOI: 10.1038/s41467-025-60862-7
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-60862-7. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.